首页> 美国卫生研究院文献>PLoS Clinical Trials >Obstructed Labor and Caesarean Delivery: The Cost and Benefit of Surgical Intervention
【2h】

Obstructed Labor and Caesarean Delivery: The Cost and Benefit of Surgical Intervention

机译:产程受阻和剖腹产:手术干预的成本和收益

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAlthough advances in the reduction of maternal mortality have been made, up to 273,000 women will die this year from obstetric etiologies. Obstructed labor (OL), most commonly treated with Caesarean delivery, has been identified as a major contributor to global maternal morbidity and mortality. We used economic and epidemiological modeling to estimate the cost per disability-adjusted life-year (DALY) averted and benefit-cost ratio of treating OL with Caesarean delivery for 49 countries identified as providing an insufficient number of Caesarean deliveries to meet demand.
机译:背景尽管在降低孕产妇死亡率方面取得了进步,但今年仍有273,000名妇女死于产科病因。已确定最常采用剖腹产手术的分娩阻塞性疾病(OL)是造成全球孕产妇发病率和死亡率的主要因素。我们使用经济和流行病学模型估算了49个国家(经剖腹分娩的数量不足以满足需求)估计的每位残疾调整生命年(DALY)避免的成本以及通过剖腹产治疗OL的收益成本比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号